This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global high-throughput screening (HTS) market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
The secondary sources referred to for this research study include publications from government sources, such as World Health Organization (WHO), American Society for Clinical Laboratory Science (ASCLS), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI), American Association for Clinical Chemistry (AACC), American Society for Pharmacology and Experimental Therapeutics (ASPET), National Health Service (NHS), Pharmaceuticals and Medical Devices Agency (PMDA), European Medicines Agency (EMA), and Center for Translational Research among others. Corporate and regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations were also used as secondary sources for this research report. Secondary data was collected and analyzed to arrive at the overall size of the global high-throughput screening (HTS) market, which was validated through primary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global high-throughput screening (HTS) market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as personnel from pharmaceutical and biopharmaceutical industries, CMOs and CROs, academic & research institutes, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across four major regions, including the Asia Pacific, North America, Europe, Latin America, and the Middle East & Africa. Approximately 80% and 20% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The global size of the market was estimated through multiple approaches. A detailed market estimation approach was followed to estimate and validate the value of the high-throughput screening (HTS) market and other dependent submarkets. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
-
The key players in the industry and market have been identified through extensive primary and secondary research.
-
The revenues generated from the high-throughput screening (HTS) business of leading players have been determined through primary and secondary research.
-
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Market Definition
High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays. This method is widely used in the pharmaceutical industry and utilizes robotics, automation, liquid handling devices, plate readers, and specialized software for instrument control and data processing. High-throughput screening (HTS) is a drug discovery process that involves automated testing of large quantities of chemical or biological compounds against specific biological targets using various binding assays. This method is widely used in the pharmaceutical industry and utilizes robotics, automation, liquid handling devices, plate readers, and specialized software for instrument control and data processing.
Stakeholders
-
Contract research organizations
-
Pharmaceutical & biopharmaceutical companies
-
Academic & research institutes
-
High-throughput screening instrument & reagent manufacturers
-
High-content screening database, service, and software providers
-
Venture capitalists & investors
-
Market research & consulting firms
-
Government associations
-
Medical institutions & universities
Report Objectives
-
To define, describe, and forecast the global high-throughput screening (HTS) market based on offerings, technology, application, end user, and region
-
To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
-
To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa
-
To profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
-
To track and analyze competitive developments such as acquisitions, product/ service launches, expansions, agreements, partnerships, and collaborations in the market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Geographical Analysis
-
Further breakdown of the Rest of Europe high-throughput screening (HTS) market, by country
-
Further breakdown of the Rest of Asia Pacific high-throughput screening (HTS) market, by country
-
Further breakdown of the Rest of Latin America and Middle East & Africa high-throughput screening (HTS) market, by country
Company Information
-
Detailed analysis and profiling of additional market players (up to five)
Growth opportunities and latent adjacency in High Throughput Screening Market